Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Beak and feather disease virus candidate vaccine development

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Duvenage, Lucian
Other Authors: Rybicki, Ed
Format: Thesis
Language:English
Published: Department of Molecular and Cell Biology 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613342278877184
access_status_str Open Access
author Duvenage, Lucian
author2 Rybicki, Ed
author_browse Duvenage, Lucian
Rybicki, Ed
author_facet Rybicki, Ed
Duvenage, Lucian
author_sort Duvenage, Lucian
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/12785
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:34:36.552Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Department of Molecular and Cell Biology
publisherStr Department of Molecular and Cell Biology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/12785 Beak and feather disease virus candidate vaccine development Duvenage, Lucian Rybicki, Ed Hitzeroth, Inga Meyers, Ann Molecular and Cell Biology Includes bibliographical references. [Fix supervisors field.] Psittacine beak and feather disease, caused by a circovirus known as beak and feather disease virus (BFDV), is a threat to both wild and captive psittacine species. There is currently no vaccine against BFDV and safe and affordable vaccine candidates are needed to alleviate the disease burden caused by this virus. Production of the BFDV's major antigenic determinant, the capsid protein (CP), in the inexpensive and highly scalable plant expression system, could satisfy these requirements as a potential subunit vaccine. In this work, truncated CP (ÄN40 CP) was first expressed in E. coli to successfully generate anti-CP polyclonal antibodies. ÄN40 CP and full-length CP transient expression in tobacco (Nicotiana benthamiana) was optimised as fusions to elastin-like polypeptide (ELP). Fusion of CP or ÄN40 CP to ELPs of different lengths was shown to increase yield relative to unfused CP/ÄN40 CP. Free ELP and a GFP-ELP fusion could be purified by inverse transition cycling (ITC), using centrifugation and membrane filtration methods. A ÄN40 CP-ELP fusion expressed in plants could be partially purified and represents low-cost vaccine candidate against BFDV. A candidate DNA vaccine expressing ÄN40 CP was also evaluated for expression of the antigen in vitro and may prove useful in a prime-boost regimen together with one of the plant-produced vaccine candidates. 2015-05-13T14:15:55Z 2015-05-13T14:15:55Z 2012 Master Thesis Masters MSc http://hdl.handle.net/11427/12785 eng application/pdf Department of Molecular and Cell Biology Faculty of Science University of Cape Town
spellingShingle Molecular and Cell Biology
Duvenage, Lucian
Beak and feather disease virus candidate vaccine development
thesis_degree_str Master's
title Beak and feather disease virus candidate vaccine development
title_full Beak and feather disease virus candidate vaccine development
title_fullStr Beak and feather disease virus candidate vaccine development
title_full_unstemmed Beak and feather disease virus candidate vaccine development
title_short Beak and feather disease virus candidate vaccine development
title_sort beak and feather disease virus candidate vaccine development
topic Molecular and Cell Biology
url http://hdl.handle.net/11427/12785
work_keys_str_mv AT duvenagelucian beakandfeatherdiseaseviruscandidatevaccinedevelopment